Next Generation Therapies

- to reduce symptoms of mental illness and retrain the brain

Aaron Beck, M.D.
Aaron Beck, M.D.
November 15, 2011
From The Quarterly, Fall 2011 Recent Foundation-funded research led by NARSAD Distinguished Investigator Grantee Aaron Beck, M.D. at the University of...
Allan T. Gulledge, Ph.D. of Dartmouth Medical School
Allan T. Gulledge, Ph.D.
November 15, 2011
From The Quarterly, Fall 2011 The chemicals that act in the brain act in other parts of the body as well─in the heart, in the respiratory system, in muscles....
Keming Gao, M.D., Ph.D. of Case Medical Center
Keming Gao, M.D., Ph.D.
November 15, 2011
From The Quarterly, Fall 2011 For people with mood disorders such as bipolar disorder or major depressive disorder─complex, heterogeneous illnesses on their...
Jennifer Gottlieb, Ph.D., NARSAD YI, Dartmouth Medical School
Jennifer Gottlieb, Ph.D.
November 15, 2011
From The Quarterly, Fall 2011 Upwards of half of people taking antipsychotic medications continue to have some symptoms of psychosis. Cognitive behavioral...
Sarah H. Lisanby, M.D., Duke University School of Medicine
Sarah H. Lisanby, M.D.
November 15, 2011
From The Quarterly, Fall 2011 A significant minority of people with depressive illness fail to respond to any currently available antidepressant medication....

Pages

Subscribe to